KIMS — Krishna Institute of Medical Sciences Balance Sheet
0.000.00%
- IN₹288.06bn
- IN₹314.91bn
- IN₹30.35bn
Annual balance sheet for Krishna Institute of Medical Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,844 | 1,901 | 1,342 | 1,320 | 1,017 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,296 | 1,581 | 2,910 | 3,308 | 4,874 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,512 | 3,934 | 4,776 | 5,474 | 6,973 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8,308 | 9,094 | 18,575 | 26,613 | 41,560 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 14,362 | 19,073 | 29,413 | 38,520 | 57,360 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,783 | 2,150 | 2,965 | 4,523 | 8,362 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 5,724 | 5,200 | 12,718 | 20,237 | 35,982 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 8,637 | 13,873 | 16,695 | 18,284 | 21,378 |
| Total Liabilities & Shareholders' Equity | 14,362 | 19,073 | 29,413 | 38,520 | 57,360 |
| Total Common Shares Outstanding |